Application of probiotic mixed preparation in preparation of product for relieving toxic and side effects of oxaliplatin chemotherapy and medicine

The invention belongs to the technical field of biological medicines, and discloses application of a probiotic mixed preparation in preparation of a product for relieving toxic and side effects of oxaliplatin chemotherapy and a medicine. Based on bifidobacteria and lactobacillus with relatively low abundance in patients with toxic and side effects in oxaliplatin chemotherapy, people with serious toxic and side effects in oxaliplatin chemotherapy can be predicted in time; according to the present invention, by increasing the amount of the Lactobacillus reuterii, the Lactobacillus johnsonii and the Bifidobacterium longum, the toxic-side effect of the oxaliplatin chemotherapy can be effectively relieved, and the prevention and the treatment of the toxic-side effect of the oxaliplatin chemotherapy can be easily achieved..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 05. Sept. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

LAN PING [VerfasserIn]
HE ZHEN [VerfasserIn]
XIE HONGYU [VerfasserIn]
WU JINJIE [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-09-05, Last update posted on www.tib.eu: 2024-03-12, Last updated: 2024-03-15

Patentnummer:

CN116687981

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000227129